Key Record Dates
| ClinicalTrials.gov Identifier: | NCT06103864 |
|---|---|
| Brief Title: | A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer |
| First Submitted : | October 23, 2023 |
| First Submitted that Met QC Criteria : | October 23, 2023 |
| First Posted : | October 27, 2023 |
| Last Update Submitted that Met QC Criteria : | April 18, 2024 |
| Last Update Posted : | April 19, 2024 |